Daga, P. ADMET Predictor - Bacterial mutagenicity model (MUT_m100). 2020.

Abstract

MUT_m100 The Ames bacterial mutagenicity test is an important regulatory screen for potential carcinogenicity. In silico prediction of Ames positivity plays two important but somewhat distinct roles in the discovery and development of biologically active compounds. A positive Ames test does not necessarily derail development of an active ingredient (AI), because some bacterial mutagens are not carcinogenic. As a practical matter, however, demonstrating non-carcinogenicity is challenging enough that having a robust predictive model for Ames mutagenicity is a very cost-effective alternative to automatically testing every active compound, especially since the model can be used to help decide which particular compounds to synthesize or purchase. In addition, regulatory guidance now allows the use of in silico predictions of mutagenicity to help justify waiving Ames testing requirements for impurities; ADMET Predictor®’s MUT_Risk qualifies as a “statistical model” under ICH M7. MUT_m100 is one of the 11 models that provide input to MUT_Risk. It is an artificial neural network ensemble (ANNE) classification model built on literature data for 1083 positive examples and 2362 negative examples from Ames tests run using Salmonella typhimurium TA100 with metabolic activation by S9 cell fractions. Of those, 166 and 351, respectively, were set aside as an external test set for which the sensitivity was 0.831 and the specificity was 0.821 with an overall concordance of 0.824. The corresponding training set performance statistics were 0.815, 0.859, and 0.845, respectively. Predictions for any compounds for which any descriptor falls more than 10% outside the range of that descriptor seen in the training data are flagged as out-of-scope, and statistically rigorous confidences (doi 10.1186/1758-2946-6-34) are provided for all in-scope predictions.